Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Scholar Rock shares surge 26% as rival Biohaven misses SMA study goal

November 26, 2024 11:13 am
The shares of Scholar Rock Holding Corp (NASDAQ: SRRK) soared 26.07% on Monday, after an experimental, muscle-preserving drug by competitor Biohaven missed its goal in a Phase 3 study of people suffering from spinal muscular atrophy (SMA). taldefgrobep alfa, a regimen of Biohaven’s drug, and a standard SMA therapy failed to significantly improve motor function […] Read more

DURECT Corp sells ALZET product line to Lafayette

November 26, 2024 10:18 am
DURECT Corporation (NASDAQ: DRRX) said on Monday that it had sold its ALZET line of osmotic pumps to Lafayette Instrument Co in a deal valued at $17.5 million. The company also said it had paid off all remaining obligations under the term loan agreement with Oxford Finance LLC. “As DURECT continues to prioritize developing larsucosterol […] Read more

Wolfe Research upgrades Jones Lang Lasalle to “Outperform”

November 26, 2024 8:00 am
Wolfe Research has upgraded Jones Lang Lasalle Inc (NYSE: JLL) to “Outperform” from “Peer Perform”, while assigning a 12-month price target of $353.00 on the stock. According to Wolfe Research, Jones Lang Lasalle benefits from capital markets comps and improved disclosure supports multiple expansion. Meanwhile, sector tailwinds from potential deregulation and tax reform may speed […] Read more

New Zealand trade deficit shrinks, NZD off 55-week low

November 25, 2024 10:01 am
New Zealand reported a trade deficit of NZD 1.5 billion in October, which compares with a NZD 1.7 billion trade gap in the same month of 2023. Total exports surged 7.5% year-on-year to NZD 5.8 billion in October. That reflected higher shipments of: – fruit (314% YoY); – precious metals, jewelry and coins (77% YoY); […] Read more

Insperity announces $0.60 quarterly dividend

November 25, 2024 8:28 am
Insperity Inc (NYSE: NSP) said on Friday that its Board of Directors had authorized a regular quarterly cash dividend of $0.60 per share of common stock. The dividend was kept unchanged from the previous quarterly dividend payment. The dividend will be paid on December 24th to shareholders of record as of the close of business […] Read more

Singapore full-year GDP growth forecast raised

November 24, 2024 11:47 am
Singapore’s Ministry of Trade and Industry has raised its full-year 2024 GDP growth forecast to “around 3.5%” from a prior range of 2% to 3%. The revision came after the latest official data showed that the Singaporean economy had expanded at an annualized rate of 5.4% in the third quarter of 2024. The latest figure […] Read more

Bentley Systems announces $0.06 quarterly dividend

November 24, 2024 9:02 am
Bentley Systems Inc (NASDAQ: BSY), an infrastructure engineering software company, said on Friday that its Board of Directors had authorized a regular quarterly cash dividend of $0.06 per share of common stock. The dividend was kept unchanged from the previous quarterly dividend payment. The dividend will be paid on December 12th to shareholders of record […] Read more

Goldman Sachs assigns “Sell” rating on EMCOR shares

November 23, 2024 4:01 pm
Goldman Sachs has initiated coverage of EMCOR’s (NYSE: EME) shares by assigning a “Sell” rating, which, as a result, drove the stock down more than 4% on Friday. The Wall Street bank assigned a 12-month price target of $445 per share on the construction company. In October, EMCOR Group reported net income of $270.3 million […] Read more

NI Holdings appoints new Chief Executive Officer

November 23, 2024 1:28 pm
NI Holdings Inc (NASDAQ: NODK) said on Friday that it had appointed Seth C. Daggett as President and Chief Executive Officer, effective December 1st. Daggett is to succeed Cindy L. Launer, who had been in the role of Interim CEO during the Board of Directors’ search for a permanent CEO. Most recently, Seth Daggett served […] Read more

Leerink Partners upgrades AbbVie shares to “Outperform”

November 23, 2024 9:11 am
AbbVie Inc’s (NYSE: ABBV) shares have been upgraded to outperform from market perform by Leerink Partners, as the firm noted the recent sell-off in the stock had led to a buying opportunity for market players. “We believe investors can take advantage of the emraclidine setback and election-related downdraft to purchase shares in this high-quality company,” […] Read more